Shots: Oncologie to conduct P-II study assessing the efficacy and safety of Bavituximab in combination with Merck’s Keytruda (pembrolizumab) in patients with 1L advanced gastric or gastroesophageal cancer enrolling ~80 […]readmore
Tags : Bavituximab